BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences Reports First Quarter 2026 Financial Results

Integra LifeSciences (IART)Integra LifeSciencesEarnings

PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026. First Quarter 2026 Highlights First quarter revenues of $391.9

Open original release

Related news

IARTIntegra LifeSciences2026-04-20 12:32 EST

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

IRIXIRIDEX2026-05-19 20:05 EST

Iridex Reports First Quarter 2026 Financial Results

HYPRHyperfine2026-05-12 20:05 EST

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

CVRXCVRx2026-05-11 20:05 EST

CVRx Reports First Quarter 2026 Financial and Operating Results

TMCITreace Medical Concepts2026-05-08 11:05 EST

Treace Medical Concepts Reports First Quarter 2026 Financial Results

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

DNLIDenali Therapeutics2026-05-07 20:01 EST

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

SGHTSight Sciences2026-05-06 20:05 EST

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

ADPTAdaptive Biotechnologies2026-05-05 20:05 EST

Adaptive Biotechnologies Reports First Quarter 2026 Financial Results

View all latest news

Integra LifeSciences

Integra LifeSciences is a medical technology company focused on regenerative tissue technologies, neurosurgery, and surgical instrumentation. Its business is centered on hospital and procedure-linked products.

Recent company news

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-05-08 12:00 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

IARTIntegra LifeSciences2026-05-05 10:00 EST

Integra LifeSciences Reports First Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-05-05 10:00 EST

Integra LifeSciences Announces Leadership Transition

IARTIntegra LifeSciences2026-04-20 12:32 EST

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

Stock data

Close
19.53 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States